Posted on 27/11/2009 in Pharmaceutical Company Product News Merck Sharpe and Dohme has offered its shareholders information on its quarterly dividends.
The company's board of directors has declared a sum of 0.38 cents (23p) per share on its common stock, to cover the first quarter of 2010.
Payments will be offered on January 8th next year to common stock shareholders of record at the close of business on December 15th 2009, the company confirmed.
It also declared a quarterly dividend of $3.75 per share on its mandatory convertible preferred stock for the same period ? a sum that will be paid on February 15th 2010 to those on record as of February 1st next year.
Additionally, Merck Sharpe and Dohme also revealed that it has approved up to $3 billion of common stock for its treasury - purchases of which will be made on the open market, in block transactions or in privately negotiated deals.
This news comes after the company received a positive recommendation from the European Medicines Agency's Committee for its fertility treatment ELONVA (corifollitropin alfa injection).
Other news stories from 27/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
